Immune Checkpoint Inhibitor-Associated Kelch-Like Protein-11 IgG Brainstem Encephalitis
Open Access
- 1 May 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 11 (3) , e200218
Abstract
Kelch-like protein-11 (KLHL11)-IgG is associated with rhombencephalitis and seminoma. It has not previously been described as a neurologic immune checkpoint inhibitor (ICI)-related adverse event (nirAE) or in association with esophageal adenocarcinoma. We describe a 61-year-old man with metastatic esophageal adenocarcinoma treated with folinic acid, fluorouracil, oxaliplatin (FOLFOX), and nivolumab, who subsequently developed diplopia, vertigo, and progressive gait ataxia after 8 weeks of treatment. Owing to a concern for ICI-associated myasthenia gravis, nivolumab was held and he was treated with prednisone and pyridostigmine. EMG showed no neuromuscular junction dysfunction, and acetylcholine-receptor antibodies were negative. Brain MRI was unrevealing. Murine brain tissue immunofluorescence assay revealed KLHL11-IgG in both serum and CSF, confirmed by cell-based assay. Tumor histopathology demonstrated poorly differentiated, highly proliferative adenocarcinoma with increased mitotic figures and cytoplasmic KLHL11 immunoreactivity. He was initiated on 6 months of cyclophosphamide in addition to FOLFOX for post-ICI-associated KLHL11-IgG rhombencephalitis. We report KLHL11-IgG rhombencephalitis associated with poorly differentiated esophageal cancer as a novel nirAE. Tumor staining revealed KLHL11 immunoreactivity, supporting a cancer-antigen-driven ICI-associated paraneoplastic syndrome. Recognition of novel nirAEs can expedite treatment and potentially prevent progressive neurologic disability.Keywords
This publication has 11 references indexed in Scilit:
- Association Between a Distinctive Autoantibody-Associated Brainstem Sensory Syndrome and Immune Checkpoint InhibitorsJAMA Neurology, 2022
- Cranial Nerve Disorders Associated With Immune Checkpoint InhibitorsNeurology, 2021
- Neurologic autoimmunity and immune checkpoint inhibitorsNeurology, 2020
- Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 EncephalitisJAMA Neurology, 2020
- Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing SpectrumAnnals of Neurology, 2020
- Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitorsNeurology Neuroimmunology & Neuroinflammation, 2019
- A case series of PD-1 inhibitor-associated paraneoplastic neurologic syndromesJournal of Neuroimmunology, 2019
- PDE10A antibodies in autoimmune encephalitisNeurology, 2019
- Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic EncephalitisNew England Journal of Medicine, 2019
- Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitorsNature Reviews Clinical Oncology, 2019